Alnylam Pharmaceuticals, Inc. (ALNY)
320.13
-13.26
(-3.98%)
USD |
NASDAQ |
Apr 16, 16:00
321.13
+1.00
(+0.31%)
After-Hours: 20:00
Alnylam Pharmaceuticals Free Cash Flow : 465.38M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.076B |
| Eli Lilly & Co. | 5.964B |
| Ionis Pharmaceuticals, Inc. | -325.67M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Sarepta Therapeutics, Inc. | -332.39M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 163.56M |
| Cash from Investing (Quarterly) | -37.17M |
| Cash from Financing (Quarterly) | 45.32M |
| Free Cash Flow Per Share (Quarterly) | 1.029 |
| Free Cash Flow to Equity (Quarterly) | -55.23M |
| Free Cash Flow to Firm (Quarterly) | 289.89M |
| Free Cash Flow Yield | 1.09% |